Clinical Trial

To Evaluate the Efficacy of CT041 in Sequential Treatment After First-line Treatment of Advanced Gastric/Esophagogastric Junction Adenocarcinoma

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy of CT041 in sequential treatment after first-line treatment of advanced gastric/esophagogastric junction adenocarcinoma
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-15.
Status change: Not Yet Recruiting → Recruiting 2025-09-25
Trial Details
NCT Number NCT07179484
Lead Sponsor Beijing GoBroad Hospital
Conditions Gastroesophageal Junction Adenocarcinoma
Enrollment 20 participants
Start Date 2025-10-22
Primary Completion 2027-09-01 (estimated)
Study Completion 2028-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-01